
News
Blackstone: Reached a $570 million term loan and revolving credit facility arrangement with biopharmaceutical company Axsome Therapeutics

Blackstone: Reached a $570 million term loan and revolving credit facility arrangement with biopharmaceutical company Axsome Therapeutics